Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors

Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors

Despite the ongoing progress in cancer research, the global cancer burden has increased to 18.1 million new cases and 9.6 million deaths in 2018. Gynecological cancers, such as ovarian, endometrial, and cervical cancers, considerably contribute to global cancer burden, leading to $5,862.6, $2,945.7,...

Full description

Bibliographic Details
Main Authors: Ewelina Grywalska, Małgorzata Sobstyl, Lechosław Putowski, Jacek Roliński
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:International Journal of Molecular Sciences
Subjects:
cytotoxic T-lymphocyte-associated antigen-4
endometrial cancer
ovarian cancer
programmed cell death protein 1
T cell exhaustion
Online Access:https://www.mdpi.com/1422-0067/20/19/4705

Internet

https://www.mdpi.com/1422-0067/20/19/4705

Similar Items